Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 03:06:54 +0200Fri, 14 Jun 2024 12:00:00 +0200Human medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation: 17/05/2024, Revision: 0, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/fabhaltaHuman medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation: 17/05/2024, Revision: 0, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/fabhaltaFri, 14 Jun 2024 12:00:00 +0200Human medicineFabhalta : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5764-en.pdfFabhalta : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-5764-en.pdfFri, 14 Jun 2024 11:11:01 +0200Human medicine